SA
Therapeutic Areas
Mebias Discovery Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MEB-1170 | Opioid Use Disorder | Phase 1 |
| S1PR1 Agonist Program | Neuropathic Pain and Neuroinflammation | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| MEB-1170 | Opioid Use Disorder | Phase 1 |
| S1PR1 Agonist Program | Neuropathic Pain and Neuroinflammation | Pre-clinical |